Written by a model from the transcript; not yet reviewed.
This episode explores the dramatic and fraught discovery of insulin in the early 1920s, tracing how a struggling Canadian surgeon named Fred Banting conceived the idea in a middle-of-the-night fever dream. Alongside graduate student Charlie Best, and later biochemist James Bertram Collip under the supervision of physiologist J.J.R. MacLeod, Banting raced against time to extract and purify pancreatic secretions that could save diabetes patients from certain death. Despite severe personal conflicts, frantic animal testing, and experimental injections of crude brown sludge, the team successfully treated a dying 14-year-old boy named Leonard Thompson in Toronto.
The narrative highlights the chaotic, high-stakes human elements behind one of modern medicine's greatest breakthroughs, including messy lab conditions, near-constant professional squabbling, and the decision by the inventors to sell their patent to the University of Toronto for just one dollar to ensure global accessibility. Ultimately, the discovery transformed a fatal diagnosis into a manageable condition, saving millions of lives while leaving a complex legacy of shared credit, oversight, and enduring gratitude from patients around the world.
The episode opens with a brief ad and then introduces Leonard Thompson, a 14‑year‑old diabetic patient in Toronto General Hospital.
The narrative shifts to Fred Banting’s background, his struggles as a surgeon, and his move to London, Ontario.
Banting’s midnight epiphany about pancreatic ducts and insulin is described, leading to his pitch to J.J.R. MacLeod.
Banting and Charlie Best begin extracting pancreatic material from dogs, facing setbacks and refining their technique.
The team injects Leonard with a purified insulin extract, marking the first successful human use of insulin.
Insulin production ramps up, the team patents the discovery, and partners with Eli Lilly to meet growing demand.
The Nobel Prize is awarded to Banting and MacLeod, sparking controversy over recognition and the eventual legacy of all four contributors.
The episode concludes with reflections on insulin’s life‑saving impact and the enduring stories of gratitude from patients.
Leonard Thompson checks into Toronto General Hospital weighing only 65 pounds, suffering from severe starvation and near death while enduring a strict 450-calorie diet.
Fred Banting's Early Strugglesstory
Before discovering insulin, Fred Banting struggled academically, failed his first year of university, and went nearly a month without a single patient at his new medical practice.
The 25-Word Middle-of-the-Night Ideainsight
Waking up at 2:00 a.m. after reading an article on diabetes research, Banting scribbled down a 25-word hypothesis involving ligating pancreatic ducts of dogs to isolate internal secretions.
Pitching a Noted Physiologistdebate
Banting traveled to the University of Toronto to pitch his sparse 25-word idea to renowned physiologist J.J.R. MacLeod, who viewed the rookie surgeon with understandable skepticism.
Banting and graduate student Charlie Best ran through the streets of Toronto rounding up stray dogs using makeshift leashes to remove their pancreases and induce diabetes for testing.
First Successful Animal Testdata
On July 30th, 1921, an extract from a dog's pancreas was injected into a terrier named 410, successfully lowering its blood glucose levels for a day before the animal succumbed.
Colip's Purified Extractstrategy
After Banting's initial trial failed, biochemist James Colip refined the purification process using adjusted levels of alcohol to create a clear extract that successfully revived Leonard Thompson.
Treating Leonard Thompsonstory
Without consulting colleague James Colip, Banting and Best administered a thick brown pancreatic extract to a dying Leonard Thompson, which resulted in sterile abscesses and no clinical benefit.
“The first patient who was successfully treated with insulin.”
“The team first partners with another Canadian lab.”
“The man once consumed by failure became the face of the drug before pioneering aviation medicine during World War II.”
Looksmaxxing, weight loss, and muscle building have fueled a massive craze for injectable peptides. Some natural and some synthetic. These injectables have unleashed a multi-billion-dollar gray-market industry online and a high-stakes frontier for the pharmaceutical industry. Today, we reach back to the quest to manufacture the first peptide-based medicine: Insulin. Guests: Alison Li, historian of science and medicine, author of J. B. Collip and the Development of Medical Research in Canada: Extracts and Enterprise Grant Maltman, curator of Banting House National Historic Site Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org http://plus.npr.org/. See pcm.adswizz.com https://pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy https://www.npr.org/about-npr/179878450/privacy-policy
6,039 words · 7 speakers
Page updated · transcript and summary are machine-generated